Prognosis of non-ST-segment elevation acute coronary syndrome in patients with prior percutaneous coronary intervention;Prognóstico da síndrome coronária aguda sem elevação do segmento ST em doentes com interveņão coronária percutânea prévia

Revista Portuguesa de Cardiologia

Volumn 24, Issue 6, 2005, Pages 805-816

  Ferreira Santos, José ^a   Ferreira, Jorge ^a   Aguiar, Carlos ^a   Gonçalves, Pedro ^a   Raposo, Luís ^a   Almeida, Manuel ^a   Seabra Gomes, Ricardo ^a  

^a HOSPITAL DE SANTA CRUZ   (Portugal)

Author keywords

Acute coronary syndrome; Angioplasty; Percutaneous coronary intervention; Prognosis

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; DEMOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RESTENOSIS; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARRHYTHMIA; CORONARY DISEASE; CORONARY RESTENOSIS; ELECTROCARDIOGRAPHY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; SYNDROME; TREATMENT OUTCOME;

EID: 23244433003     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40(7):1366-74.
2. Boden WE. "Routine Invasive" Versus "Selective Invasive" Approaches to Non-ST-Segment Elevation Acute Coronary Syndromes Management in the Post-Stent/Platelet Inhibition Era. J Am Coll Cardiol, 2003;41(4):113S-112S
3. Antman EM, Cohen M, Bernink P, et al. The TIMI Risk Score for Unstable Angina/Non-ST Elevation MI - A Method for Prognostication and Therapeutic Decision Making. JAMA, 2000;284(7):835-42.
4. Boersma E, Pieper K, Steyerberg E, et al. Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation - Results From an International Trial of 9461 Patients. Circulation, 2000;101:2557-67.
5. Granger C, Goldberg R, Dabbous O, et al. Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events. Arch Intern Med, 2003;163:2345-53.
6. Sabatine MS, Januzzi JL, Snapinn S, Theroux P, Jang IK. A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris. Am J Cardiol, 2001;88(5):488-92.
7. Collinson J, Flather MD, Fox KA et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur Heart J, 2000;21(17):1450-7.
8. Cutlip D, Baim D, Ho K et al. Stent Thrombosis in the Modern Era. A Pooled Analysis of Multicenter Coronary Stent Clinical Trials. Circulation, 2001;103:1967-71.
9. Chen LC, Chen YH, Lin SJ. Clinical and angiographic determinants of adverse cardiac events in patients with stent restenosis. Catheter Cardiovasc Interv, 2002;55(3):331-7.
10. Morrow D, Antman E, Snapinn S, McCabe C, Theroux P, Braunwald E. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J, 2002;23(3):223-9.
11. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med, 1998;339(7):436-43.
12. Bertrand M, Simoons M, Fox K et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force Report. Eur Heart J, 2002;23:1809-40.
13. Antman E, McCabe C, Gurfinkel E et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the Thrombolysis In Myocardial Infarction (TIMI) 11B trial. Circulation, 1999;100(15):1593-601.
14. Roubin G, Douglas J, King S et al. Influence of balloon size on initial success, acute complications, and restenosis after percutaneous transluminal coronary angioplasty. A prospective randomized study. Circulation, 1988;78(3):557-65.
15. Weintraub WS, Ghazzal ZM, Douglas JS et al. Initial management and long-term clinical outcome of restenosis after initially successful percutaneous transluminal coronary angioplasty. Am J Cardiol, 1992;70(1):47-55
16. Espinola-Klein C, Rupprecht HJ, Erbel R, Nafe B, Brennecke R, Meyer J. Impact of restenosis 10 years after coronary angioplasty. Eur Heart J, 1998;19:1047-53.
17. Liu M, Roubin G, King S. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation, 1989;79(6):1374-87.
18. Weintraub WS, Ghazzal ZM, Douglas JS et al. Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty. Circulation, 1993;87(3):831-40.
19. Ishiwata S, Nakanishi S, Nishiyama S, Seki A. Causes of coronary events after successful coronary angioplasty. Coronary Artery Disease, 1996;7:573-7.
20. Rodes J, Tanguay J, Bertrand O et al. Late (> 48 hr) myocardial infarction after PTCA: clinical and angiographic characteristics of infarction related or not to the angioplasty site. Catheter Cardiovasc Interv, 2001;53(2):155-62.